Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare Technologies's Beginning Cash Position for the quarter that ended in Jun. 2026 was €1,987 Mil.
GE HealthCare Technologies's quarterly Beginning Cash Position
increased
from Dec. 2025 (€3,441 Mil) to Mar. 2026 (€3,905 Mil) but then
declined
from Mar. 2026 (€3,905 Mil) to Jun. 2026 (€1,987 Mil).
GE HealthCare Technologies's annual Beginning Cash Position
increased
from Dec. 2023 (€1,331 Mil) to Dec. 2024 (€2,393 Mil) and
increased
from Dec. 2024 (€2,393 Mil) to Dec. 2025 (€2,470 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies Beginning Cash Position Chart
What does a Beginning Cash Position of €1,987 Mil mean?
GE HealthCare Technologies (MIL:1GEHC) has a Beginning Cash Position of €1,987 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on GE HealthCare Technologies and its competitors.
Is GE HealthCare Technologies' Beginning Cash Position too high?
GE HealthCare Technologies' current Beginning Cash Position is €1,987 Mil. Overall, GE HealthCare Technologies has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Beginning Cash Position compare to DXCM and STE?
GE HealthCare Technologies' Beginning Cash Position of €1,987 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current Beginning Cash Position is €1,987 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MIL:1GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €73.73, compared to a current price of €59.66 — trading 19.1% below its estimated fair value. The current Beginning Cash Position is €1,987 Mil. GE HealthCare Technologies' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For GE HealthCare Technologies (MIL:1GEHC), the current Beginning Cash Position is €1,987 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MIL:1GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of €59.66 is trading 19.1% below its estimated GF Value™ of €73.73.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MIL:1GEHC:
Beginning Cash Position: €1,987 Mil
GF Value™: €73.73 vs. price of €59.66 (19.1% below fair value)
No single metric tells the full story. See the MIL:1GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
53GF Score
Get the complete analysis for MIL:1GEHC
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1GEHC has been successfully added to your 
